Catalyst Funds Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-325	Closed	-$3.17K	–	454
2024 Q3	$3.17K	Hold	325	–	–	﹤0.01%	1259
2024 Q2	$6.66K	Buy	+325	New	+$6.66K	﹤0.01%	1008